Vitiligo Treatment in Kuwait
Vitiligo is an autoimmune disease in which the immune system attacks the pigment-producing cells, leaving sharply defined white patches. Treatment works, and works well in certain sites, but results vary enormously with the location of the patch and how long it has been there.
What you should know
- Vitiligo affects 0.5% to 2% of the population; the average age of onset is between 20 and 24, and 80% of all cases appear before the age of 30.
- Vitiligo is an autoimmune disease, not an infection; it does not spread by contact, by shaking hands, or by sharing personal items — this is the first point I clarify with a patient's family.
- Vitiligo is associated with autoimmune thyroid disease in up to 15% of affected adults and 5% to 10% of affected children, which is why I check thyroid function routinely at diagnosis.
- The patches are far more conspicuous in darker skin because of the sharp colour contrast, which makes the psychological and social burden considerably heavier for our patients in the Gulf — and that is a genuine factor in treatment decisions.
- The face and neck respond better than the trunk, the trunk responds better than the limbs, and response on the hands and feet is very poor indeed — a fact I set out plainly before starting any plan.
- Features that predict a poorer response include longstanding disease, white hairs within the patch, mucosal involvement, and new patches appearing at sites of friction or injury.
Treatment options
- Topical corticosteroids for up to three months on the trunk and limbs, while I prefer topical calcineurin inhibitors for the face, eyelids and neck because they do not cause skin atrophy with prolonged use on these delicate sites.
- Narrowband UVB phototherapy twice weekly for a trial period of three to four months; a marked or clinically useful response was achieved in 36% of patients at twelve months — so a good response in roughly a third, not in everyone.
- Ruxolitinib cream, a JAK inhibitor: 75% repigmentation of the face in 29.8% and 30.9% of patients at week 24, versus 7.4% and 11.4% on vehicle, across two trials enrolling 674 patients.
- Surgical melanocyte transplantation or grafting for stable disease, particularly segmental vitiligo that has stopped spreading; this is an option for carefully selected patients, not for everyone.
- Cosmetic camouflage and daily sun protection; the patches contain no melanin and burn far more readily, which makes this a medical necessity under the Kuwaiti sun rather than a cosmetic matter.
The single most important thing to understand is that relapse is common after treatment stops. Treatments that block the immune pathway genuinely do restore pigment, but resident memory immune cells persist in the skin and attack the pigment cells again once treatment ends. We therefore usually plan a maintenance phase — and no treatment available today can guarantee that new patches will not appear.
Frequently asked questions
Is vitiligo contagious?
No, not at all. Vitiligo is an autoimmune disease in which the immune system attacks the skin's pigment cells; it is not a bacterial, viral or fungal infection. It does not pass by contact, handshakes, sharing items, or swimming in the same pool.
Does vitiligo come back after successful treatment?
Yes — relapse is common after stopping treatment. The reason is that resident memory immune cells remain in the skin and resume attacking the pigment cells once treatment ends. This is why we discuss maintenance treatment from the outset rather than stopping everything the moment colour returns.
Why are my hands not responding when my face has improved?
This is an expected pattern, not a treatment failure. Face and neck respond better than trunk, trunk better than limbs, and the hands and feet respond very poorly because they have few hair follicles, which are the reservoir the pigment cells repopulate from. So we set different goals for different sites.
How long does phototherapy take before we know it is working?
We allow a trial period of three to four months at two sessions per week. If repigmentation appears we continue, potentially for one to two years. If there is no response at all during the trial period, it is more honest to change the plan than to continue without benefit.
Book an appointment
My private clinic at Kuwait Hospital (Sabah Al-Salem) — direct assessment and a treatment plan built around your case.
Book on WhatsAppPatient advice sheets
Short, practical sheets to read before or after your visit.